Medworxx Solutions Inc. Closes Private Placement Offering of Units

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN
THE UNITED STATES 


Medworxx Solutions Inc. ("Medworxx" or the "Corporation") (TSX VENTURE:MWX) is
pleased to announce that it has closed its previously announced private
placement with Paradigm Capital Inc., acting as lead agent and sole bookrunner,
and MGI Securities Inc. (the "Agents") on a best efforts agency basis. The
Corporation issued today 9,136,754 units (the "Units") at a price of $0.34 per
Unit for aggregate gross proceeds of $3,106,496 (the "Offering"). Each Unit is
comprised of one common share and one half of one common share purchase warrant,
with each whole warrant entitling the holder thereof to acquire one common share
of the Corporation at a price of $0.40 for a period of 48 months following the
closing of the Offering, subject to early expiry at the option of the Company in
the event that, at any time following the date that is twenty-four months from
their issuance date, the closing price of the Corporation's common shares on any
nationally recognized stock exchange is greater than $0.85 for a period of
twenty trading days in any consecutive two-month period.  


On closing, the Agents received a cash commission equal to 8% of the gross
proceeds raised by the Agents in the Offering as well as broker compensation
options entitling the holders to acquire 716,456 Units for a period of 24 months
from the closing date, with such Units, upon issuance, having the same terms and
conditions as the Units sold pursuant to the Offering. In addition, the Agents
were granted an over-allotment option to sell up to an additional 15% of the
number of Units sold in the Offering, which option was exercised on closing for
the issuance of 661,577 Units and such Units are included the total number of
Units issued as stated above. 


The proceeds from the sale of the Units will be used for sales, general and
administrative expenditures to increase the Corporation's sales for across North
America and the United Kingdom, and for general working capital purposes. 


"Medworxx is well-positioned to build on our success in the Canadian and UK
markets as we expand internationally. Our investor base, which now includes a
strong institutional contingent, has given a vote of confidence that we'll come
out of the gates with strength to leverage this increased working capital," said
Dan Matlow, CEO and President of Medworxx Inc. 


All of the securities issued in connection with the Offering are subject to a
hold period expiring on September 25, 2012.


About Medworxx 

Medworxx delivers health information technology solutions to over 300 clients
internationally; including Canada, United States and United Kingdom. Medworxx
helps hospitals meet patient flow challenges, and requirements in compliance and
education. Medworxx Utilization Management system-flagship of Medworxx PF that
also includes bed optimization and independent assessment components-currently
serves over 30% of the acute care beds in Canada. Founded in 2004, Medworxx Inc.
is based in Toronto, ON, and publicly traded on the TSX Venture Exchange: MWX. 




--  Online: www.medworxx.com 
--  LinkedIn: www.linkedin.com/company/medworxx 
--  Twitter: @Medworxx



Disclaimers: The statements made in this press release may contain
forward-looking statements that involve a number of risks and uncertainties.
Actual events or results could differ materially from the Company's expectations
and projections. Forward-looking statements involve known and unknown risks,
uncertainties and other factors, such as competition, technological changes, the
changing needs of hospitals, the financial condition of the Company's current
and potential customers, foreign currency exchange rates, as well as general
economic conditions, which may cause the actual results, performance or
achievements of the Company to be materially different from any future results,
performance or achievements expressed or implied by the forward-looking
statements. The Company is under no obligation to update forward-looking
statements.